Kathryn Giusti

Founder at

The Multiple Myeloma Research Foundation, Inc.

67 year

67 connections

Health Technology

Consumer Services

Commercial Services

Profile

Kathryn E.
Giusti is the founder of The Multiple Myeloma Research Foundation, Inc. (founded in 1998) where she holds the title of Director.
She was also the founder of the Multiple Myeloma Research Consortium (founded in 2004) where she held the title of Chief Executive Officer.
In addition, she is the founder of the Kraft Precision Medicine Accelerator at Harvard Business School (founded in 2016) where she holds the title of Co-Chairman.
Ms. Giusti's current job(s) include being a Director at EQRx International, Inc. (since 2021) and a Member at FasterCures.
Her former job(s) include being a Director at IQVIA, Inc., Executive Director-Worldwide Arthritis Franchise at G.D.
Searle & Co., Inc. (from 1992 to 1997), Independent Director at EQRx, Inc. (from 2021 to 2023), and Principal at Merck & Co., Inc. (from 1980 to 1983).
Ms. Giusti's education history includes an undergraduate degree from the University of Vermont and an MBA from Harvard Business School.

Kathryn Giusti active positions

Companies	Position	Start
The Multiple Myeloma Research Foundation, Inc. The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment	Founder	01/01/1998
EQRx International, Inc. EQRx International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines	Director/Board Member	27/09/2021
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Founder	01/01/2016
FasterCures	Corporate Officer/Principal	-

All active positions of Kathryn Giusti

Former positions of Kathryn Giusti

Companies	Position	End
EQRX, INC.	Director/Board Member	09/11/2023
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Corporate Officer/Principal	01/03/1997
MERCK & CO., INC.	Corporate Officer/Principal	01/01/1983
Multiple Myeloma Research Consortium Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development	Chief Executive Officer	-
IMS HEALTH, INC.	Director/Board Member	-

See the detail of Kathryn Giusti's experience

Training of Kathryn Giusti

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kathryn Giusti's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
IQVIA, Inc. IQVIA, Inc. Packaged SoftwareTechnology Services Provides AI assistant, analytics and clinical research services for healthcare sector	Technology Services
G.D. Searle & Co., Inc. G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products	Process Industries
University of Vermont University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
FasterCures
The Multiple Myeloma Research Foundation, Inc. The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment	Commercial Services
Multiple Myeloma Research Consortium Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development	Commercial Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
EQRx International, Inc. EQRx International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines	Health Technology
EQRx, Inc. EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer	Health Technology